Ulrika Marking

769 total citations
10 papers, 96 citations indexed

About

Ulrika Marking is a scholar working on Infectious Diseases, Modeling and Simulation and Clinical Psychology. According to data from OpenAlex, Ulrika Marking has authored 10 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Modeling and Simulation and 2 papers in Clinical Psychology. Recurrent topics in Ulrika Marking's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 epidemiological studies (3 papers). Ulrika Marking is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 epidemiological studies (3 papers). Ulrika Marking collaborates with scholars based in Sweden, Netherlands and Switzerland. Ulrika Marking's co-authors include Charlotte Thålin, Jonas Klingström, Sebastian Havervall, Kim Blom, Mikael Åberg, Nina Greilert‐Norin, Henry Ng, Max Gordon, Sara M. Mangsbo and Peter Nilsson and has published in prestigious journals such as Nature Communications, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Ulrika Marking

9 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrika Marking Sweden 6 79 12 11 11 11 10 96
Benjamin Chung United States 2 105 1.3× 23 1.9× 16 1.5× 5 0.5× 8 0.7× 2 123
Jordi Chi Spain 5 101 1.3× 8 0.7× 28 2.5× 8 0.7× 13 1.2× 5 135
Bas Wintermans Netherlands 4 163 2.1× 14 1.2× 8 0.7× 6 0.5× 11 1.0× 8 173
Victoria Giffin United States 2 103 1.3× 23 1.9× 16 1.5× 5 0.5× 7 0.6× 3 122
Jessica Miller United States 6 95 1.2× 7 0.6× 21 1.9× 6 0.5× 10 0.9× 9 121
Nina Greilert‐Norin Sweden 6 73 0.9× 14 1.2× 9 0.8× 11 1.0× 10 0.9× 9 90
Eva Bednarski United States 4 113 1.4× 9 0.8× 22 2.0× 8 0.7× 22 2.0× 5 124
Laura E. Avena United States 7 135 1.7× 6 0.5× 18 1.6× 10 0.9× 13 1.2× 7 165
Sarah Ducat United States 3 128 1.6× 29 2.4× 18 1.6× 5 0.5× 7 0.6× 3 148
Joseph R. Allen United States 5 131 1.7× 7 0.6× 17 1.5× 9 0.8× 4 0.4× 5 156

Countries citing papers authored by Ulrika Marking

Since Specialization
Citations

This map shows the geographic impact of Ulrika Marking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Marking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Marking more than expected).

Fields of papers citing papers by Ulrika Marking

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika Marking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Marking. The network helps show where Ulrika Marking may publish in the future.

Co-authorship network of co-authors of Ulrika Marking

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika Marking. A scholar is included among the top collaborators of Ulrika Marking based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika Marking. Ulrika Marking is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Marking, Ulrika, Katherina Aguilera, Tamás Pongrácz, et al.. (2025). Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection. EBioMedicine. 120. 105912–105912. 1 indexed citations
2.
Aguilera, Katherina, Ulrika Marking, Nina Greilert‐Norin, et al.. (2024). Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023. The Lancet Regional Health - Europe. 38. 100872–100872.
3.
Aguilera, Katherina, Ulrika Marking, Nina Greilert‐Norin, et al.. (2024). Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum. Frontiers in Immunology. 15. 1346749–1346749. 11 indexed citations
4.
Blom, Kim, Sebastian Havervall, Ulrika Marking, et al.. (2023). Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden. The Lancet Regional Health - Europe. 33. 100725–100725. 2 indexed citations
5.
Marking, Ulrika, Sebastian Havervall, Nina Greilert‐Norin, et al.. (2023). Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers. Nature Communications. 14(1). 1577–1577. 12 indexed citations
6.
Havervall, Sebastian, Ulrika Marking, Nina Greilert‐Norin, et al.. (2022). Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time. Clinical & Translational Immunology. 11(4). e1388–e1388. 13 indexed citations
7.
Marking, Ulrika, Sebastian Havervall, Nina Greilert‐Norin, et al.. (2022). Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines. Vaccines. 10(3). 359–359. 7 indexed citations
8.
Mangsbo, Sara M., Sebastian Havervall, Robin S. Lindsay, et al.. (2021). An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses. PLoS ONE. 16(9). e0258041–e0258041. 5 indexed citations
9.
Havervall, Sebastian, Ulrika Marking, Nina Greilert‐Norin, et al.. (2021). Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2. EBioMedicine. 70. 103523–103523. 32 indexed citations
10.
Marking, Ulrika, Margriet den Boer, Asish Kumar Das, et al.. (2014). Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh—A Case Report. PLoS neglected tropical diseases. 8(6). e2864–e2864. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Chung Breakdown of academic impact, for papers by Jordi Chi Breakdown of academic impact, for papers by Bas Wintermans Breakdown of academic impact, for papers by Victoria Giffin Breakdown of academic impact, for papers by Jessica Miller Breakdown of academic impact, for papers by Nina Greilert‐Norin Breakdown of academic impact, for papers by Eva Bednarski Breakdown of academic impact, for papers by Laura E. Avena Breakdown of academic impact, for papers by Sarah Ducat Breakdown of academic impact, for papers by Joseph R. Allen
Rankless by CCL
2026